DAILY aspirin can reduce the chances of dying from bowel cancer by almost a third, research has shown.
Patients who took aspirin daily for at least nine months after being diagnosed with the disease cut their chances of death by 30%.
Taking aspirin for any length of time after diagnosis reduced the odds of dying from cancer by 23% compared with not taking aspirin at all.
The study looked at 4500 bowel cancer patients in the Netherlands, diagnosed between 1998 and 2007.
A quarter were not aspirin users, another quarter only took aspirin after diagnosis, while the remaining group took it both before and after developing cancer.
Lead researcher Dr Gerrit-Jan Liefers, from Leiden University Medical Centre in the Netherlands, said their findings could have profound clinical implications.
"In this study, we showed the therapeutic effect of a widely available, familiar drug that costs mere pennies per day," he said.
"It's possible that some older people may have other health problems, which mean that they are not well enough to have chemotherapy.
"Bowel cancer is more common in older people, so these results could be a big advance in treatment of the disease, particularly in this group."
But he says further research was needed to confirm this.
His team is now planning a randomised controlled trial, due to start later this year, which will target people older than 70.
Sarah Lyness, executive director of policy and information at Cancer Research UK, said the latest study added to the growing evidence about the benefits of aspirin.
"But we are not yet at the point where we would recommend people start taking aspirin to reduce their chances of developing cancer,? she said.
?There are still questions we need to answer about the side effects, such as internal bleeding, who might benefit most from taking aspirin, who might be harmed, what dose and how long some people might want to take it for."
commercial loans Homestead insurance las vegas Messi Lionel mopar parts online
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন